Post‐diagnosis smoking habit change and incident dementia in cancer survivors

by Clinical Neuropsychologist | Friday, August 9, 2024 | Dementia

Abstract INTRODUCTION Many individuals change their smoking habits after cancer diagnosis. We aimed to evaluate the association of post-diagnosis smoking habit change with incident dementia in cancer survivors. METHODS We identified 558,127 individuals who were...

Carers and professionals’ views on using virtual reality in dementia care: A qualitative study

by Clinical Neuropsychologist | Friday, August 9, 2024 | Dementia

Dementia, Volume 24, Issue 1, Page 71-90, January 2025. Background and ObjectivesVirtual reality (VR) interventions provide immersive, interactive computer-simulated virtual environments. There is interest in their use for people with dementia as they may provide...

People with dementia and family carers are welcoming of a model of dementia palliative care, but sceptical of its implementation

by Clinical Neuropsychologist | Friday, August 9, 2024 | Dementia

Dementia, Volume 24, Issue 1, Page 91-110, January 2025. IntroductionA palliative care approach can improve quality-of-life for people with dementia. It is the preference of many people with dementia to remain living at home until death, with the appropriate care. To...

Patient-reported experience measures for people living with dementia: A scoping review

by Clinical Neuropsychologist | Friday, August 9, 2024 | Dementia

Dementia, Volume 23, Issue 8, Page 1354-1381, November 2024. The prevalence of dementia is increasing globally, with an estimated 139 million people expected to be living with dementia by 2050. Across numerous countries, substandard care for people with dementia is...

Design and validation of the ADNI MR protocol

by Clinical Neuropsychologist | Thursday, August 8, 2024 | Dementia

Abstract Phase four of the Alzheimer’s Disease Neuroimaging Initiative (ADNI4) magnetic resonance imaging (MRI) protocols aim to maintain longitudinal consistency across two decades of data acquisition, while adopting new technologies. Here we describe and...

Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease

by Clinical Neuropsychologist | Thursday, August 8, 2024 | Dementia

Abstract INTRODUCTION Clonal hematopoiesis of indeterminate potential (CHIP) and dementia disproportionately burden patients with chronic kidney disease (CKD). The association between CHIP and cognitive impairment in CKD patients is unknown. METHODS We conducted...